Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

PCRX·NASDAQ

$22.32

+0.31%
HealthcareDrug Manufacturers - Specialty & Generic

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

At a Glance

Live Snapshot
Market Cap$877.96M
EPS0.1600
P/E Ratio139.50
Earnings Date08/04/2026

pcrx

Revenue

Last Annual Value

726.41M

3-Year CAGR

3%

5-Year CAGR

11%

10-Year CAGR

11%

Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Competitors Analysis of Revenue

PCRX · NASDAQ
CompanyRevenue
CAGR 3Y
CAGR 5Y
CAGR 10Y
726.41M
2.5%6.1%10.1% 
175.11M
535.6%N/AN/A
1.01B
10.7%7.6%28.3%
ANAB logo
AnaptysBio, Inc.
NASDAQ:ANAB
234.60M
139.1%30.0%30.3%
0.00
N/AN/AN/A
XNCR logo
Xencor, Inc.
NASDAQ:XNCR
125.58M
-10.4%-14.5%3.7%
109.79M
9.9%18.0%20.1%
0.00
N/AN/AN/A
Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Fair Value Envelope

PCRX · NASDAQ

Our analysis suggests that PCRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $22.32, this represents a potential HIDDEN relative to our calculated worth for Pacira BioSciences, Inc..

Intrinsic Value
Current Price: $22.32